home| hec pharm
home - investor - regulatory affairs
regulatory affairs

our regulatory affairs team includes more than 70 people. they have successfully completed dossier submission to the us and european countries. several andas and inds (for nce) have been approved by international regulatory authorities. one of our products azithromycin tablet is listed on who prequalified medicine list, and more than 20dmfs and ceps are available.

星力游戏官方网 copyright hec pharma co., ltd license key: